Skip to main content
. 2011 Jun 8;9(66):147–157. doi: 10.1098/rsif.2011.0220

Figure 5.

Figure 5.

Three-dimensional endothelial cell migration was enhanced by low-dose plasma treatment via ROS-induced FGF-2 release. (a) Plasma-treated PAEC were added to the upper compartment of a Boyden chamber, with or without a neutralizing FGF-2 antibody, and migrated cells on the well bottom were measured. *p < 0.01 compared with control. †p < 0.01 compared with plasma. **p < 0.001 compared with control. ††p < 0.001. (b) To block the ROS effects, cells were plasma-treated in the presence of extracellular ROS scavenger SP. #p < 0.05 compared with control, +p < 0.05 compared with plasma.